Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-20-027966

Options or other derivatives

  • Director acquired 1,428 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gross Jane A Director 2020-05-06 Grant or award · Stock Option (right to buy) +1,428 1,428 D: show line 1 in the form
Loading xslF345X03/doc4.xml…